Supplementary Data from Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells
Authors:
- Young-Kwang YoonYYYoung-Kwang Yoon
- Hwang-Phill KimHKHwang-Phill Kim
- Sae-Won HanSHSae-Won Han
- Hyung-Seok HurHHHyung-Seok Hur
- Do Youn OhDODo Youn Oh
- Seock-Ah ImSISeock-Ah Im
- Yung-Jue BangYBYung-Jue Bang
- Tae-You KimTKTae-You Kim
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)